Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01517958 · ClinicalTrials.gov registry record
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
A clinical trial of Respiratory Distress Syndrome and Transient Tachypnea of the Newborn, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT01517958: Completed study of Respiratory Distress Syndrome and Transient Tachypnea of the Newborn, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01517958 is a study of Respiratory Distress Syndrome and Transient Tachypnea of the Newborn that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 36 participants, below the 230-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01517958, a study of Respiratory Distress Syndrome and Transient Tachypnea of the Newborn, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that ultrasonography of the newborn lung can be used as an effective diagnostic tool in neonates ≥ 28 weeks gestation with early symptoms of respiratory distress.
Primary Outcome
The primary endpoint is to determine whether lung ultrasound is comparable or superior to chest radiography: (1) in making the diagnosis of RDS and TTN and (2) in differentiating between RDS and TTN. Disease-specific lung ultrasound findings: (1) Double lung point in TTN and (2) lung white-out in RDS.
Conditions Studied
Interventions
- OTHER Control Group
- OTHER Respiratory Distress Group
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-06 |
What the finished NCT01517958 record still lists
NCT01517958 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 230-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (84% lower).
The record links to 4 conditions, with Respiratory Distress Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Control Group is the first listed.
NCT01517958 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01517958 about?
NCT01517958 is a clinical study titled "Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates". The investigators hypothesize that ultrasonography of the newborn lung can be used as an effective diagnostic tool in neonates ≥ 28 weeks gestation with early symptoms of respiratory distress.
What is the current status of trial NCT01517958?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2011-10. Estimated completion is 2013-06.
What conditions does trial NCT01517958 study?
This clinical trial studies the following conditions: Respiratory Distress Syndrome, Transient Tachypnea of the Newborn, TTN, RDS.
What interventions are being tested in trial NCT01517958?
The interventions under investigation include: Control Group (OTHER), Respiratory Distress Group (OTHER).
Who is sponsoring clinical trial NCT01517958?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01517958 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01517958's enrollment target sits among peer trials
36 7th of 8 higher than 2 of 8 other Respiratory Distress Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Distress Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non Inferiority Trial Investigating Surfactants Administered Via MIST
RECRUITING · Phase 4
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
RECRUITING · Phase 3
-
Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients
RECRUITING · NA
-
The Budesonide in Babies (BiB) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia